Jin Medical International Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $20.7M-12.0% YoYTTM through 30 Sep 2025
Net Income $1.2M-67.6% YoYTTM through 30 Sep 2025
Free Cash Flow -$3.7MTTM through 30 Sep 2025
Margins
| Current | |
|---|---|
| Gross Margin | 29.2% |
| EBITDA Margin | 4.1% |
| Operating Margin | 2.9% |
| Net Margin | 5.8% |
Returns
4.8%ROE
0.8%ROA
2.8%ROIC
Balance Sheet Health
Debt / Equity0.64x
Current Ratio1.86x
Net Debt-$10.7Mnet cash position
Cash & Equivalents$7.5M
Quality Metrics
Altman Z-Score5.35
Piotroski F-Score4 / 9
FCF Margin-18.0%
Multi-Year Trend
RevenueFY2025: $20.7M
Diluted EPS$0.01TTMFY2025: $0.01
Dividend
No dividend
Capital Allocation
R&D Spend$1.6M
Capex Intensity32.0%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.